|
Form Serial Number: |
DB20180104E00119 |
1.
Date of relevant event: |
10/10/2017 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event / interest in the shares (if later): |
02/11/2017 (dd/mm/yyyy)
|
3.
Stock code: |
01548 |
4.
Name of listed corporation: |
Genscript Biotech Corporation |
5.
Name of associated corporation of listed corporation: |
Genscript Corporation |
6.
Registered office: |
c/o The Corporation Trust Company, 1209 Orange Street, Wilmington, Delaware 19801, United States of America |
7.
Principal place of business: |
c/o The Corporation Trust Company, 1209 Orange Street, Wilmington, Delaware 19801, United States of America |
8.
Class of shares in which interested: |
common stock |
9.
Number of issued shares in class: |
466,110,625 |
12.
Exchange on which listed: |
|
13.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Wang |
(Other names) |
Luquan |
|
|
|
16.
Name of director (Chinese): |
王鲁泉 |
17.
Chinese Character Code as printed on HKID Card: |
|
|
30.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
Long position |
1201 | The number of shares in which you are interested has reduced because: you completed a sale of the shares |
|
|
|
463,125 |
USD |
|
|
0.5363 |
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
|
31.
Total shares immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 108,077,728 | 23.19 |
|
|
32.
Total shares immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 107,614,603 | 23.14 |
|
|
33.
Capacity in which interests disclosed in Box 32 are held: |
Capacity code | Number of shares |
| |
|
|
34.
Further information in derivative interests in associated corporation: |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by associated corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | |
|
|
35.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
36.
Further information in relation to interests of corporations controlled by director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
|
37.
Further information in relation to interests held by director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
38.
Further information from a trustee, a beneficiary of a trust, or a person who has set up a discretionary trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
39.
Supplementary information: |
|
40.
Log/Serial Number of the previous form: |
|
Date of filing this Form 3B: |
04/01/2018 (dd/mm/yyyy)
|
|